Introduction
Rheumatoid arthritis (RA) is an autoimmune disease whose etiology is unknown, while its immunopathogenesis involves the participation of both genetic and environmental factors. Human leukocyte antigen DR4 (HLA-DR4) exhibits a strong association with RA in various populations and ethnic groups; in addition, a heightened frequency of HLA-DR1 among individuals with RA has been found in some populations [1] [2] [3] [4] . According to several studies, the presence of HLA-DR4 is more strongly associated with aggressive RA, characterized by the progression of radiological erosion, positive rheumatoid factor (RF) and extra-articular manifestations, than with susceptibility to the disease [5] [6] [7] .
Homozygosity for the HLA-DR1 allele with shared epitope, The average age of the sample was 47.3 years old; the average length of disease was 7.72 years; and 84 (87%) participants tested positive for RF. Extra-articular manifestations (subcutaneous nodules, anemia, skin ulcers, Raynaud's phenomenon) were identified in 54 participants (56%), most frequently subcutaneous nodules (19%); 32 volunteers (33.0%) exhibited more than one type of extra-articular manifestation. Pulmonary symptoms were found in 35 participants (36.0%), most frequently dyspnea (20.0%), chest pain (13.0%), dry cough (11.0%) and productive cough (10.0%) ( Table 1) .
Lung involvement
The pulmonary function test (PFT) results were normal in 65 participants (67.0%), while 12 (12.0%) exhibited restrictive ventilatory defect, 18 (19.0%) obstructive ventilatory defect and 2 (2.0%) a mixed pattern (Table 2) .
On HRCT, the results were normal in 57 (59.0%) participants, while nodules were found in 12 (12.0%) and fibrosis in 31 (32.0%) ( Table 3 ). Joint analysis of the HRCT and PFT results indicated lung affection in 54 (55.7%) participants.
to detect interstitial lung disease in 50% of the participants with RA, whereas only 10% of them exhibited relevant clinical symptoms [20] .
The possibility of establishing the risk of severe and destructive joint and extra-articular manifestations of RA early in the course of disease might contribute to the prevention of irreversible joint and systemic damage [21] .
As the Brazilian population exhibits genetic diversity, with variable patterns of DR alleles and haplotypes, the assessment of DR alleles in a population of individuals from Piaui with rheumatoid lung disease might contribute to assessing the prognosis of patients with that condition.
Participants and Methods

Participants
Ninety-seven patients diagnosed with RA according to the American College of Rheumatology (ACR( revised criteria [22] , were selected during the years of 2011 and 2012. The volunteers were followed-up by the same physician at a university hospital and at the physician's private office and were requested to respond to a questionnaire including data on the age at onset, length of disease and the presence or absence of extra-articular manifestations. They agreed to participate in the study after reading and signing the Consent Form approved by the Medical Ethics Committee.
A total of 85 participants (88.0%) were female; 77.0% were nonwhite; and the average age of the sample was 47.3 years old. A total of 54 participants (56.0%) exhibited extra-articular manifestations, most frequently subcutaneous nodules (19.0%).
Detection of rheumatoid factor
RF was detected by the quantitative method of nephelometry and the values were considered positive when > 30 IU/mL.
High-resolution computed tomography of the lungs
The volunteers were subjected to HRCT, which was performed in a supine position, using a Siemens Somatom Spirit scanner with two channels and GE Healthcare LightSpeed Pro 16; all the scans were encoded.
Pulmonary function test
All participants were subjected to spirometry using a Beatrice Pulmonary Assessment System (Sistema de Avaliação Pulmonar Beatrice -PC). The device was coupled to a computer, and the results were compared to the predicted values for healthy individuals of the same age, gender and height (Brazilian Society of Pneumology and Phthisiology/Sociedade Brasileira de Pneumologia e Tisiologia -SBPT) using the reference values used described by PEREIRA et al. [23] .
HLA genotyping
Typification of class II HLA alleles was carried out through the DNA/PCR/SSP molecular method at medium and high resolution. DNA was extracted through a salting-out procedure of peripheral blood of each individual participating in the research. The alleles were quantified at a medium or generic resolution using the PCR/SSP technique for primers of "One Lambda"(One Lambda Inc., CA, UK).
Statistical analysis
The frequency of each HLA-DR subtype was established together with the corresponding confidence interval. The correlation between HLA and lung affection was assessed using the chi-square test, and the risk was estimated by calculating the odds ratios, the corresponding confidence interval and bivariate analysis.
Results
Clinical characteristics
Most participants were female (88.0%) and non-white (77%). 
HLA-DRB alleles and lung affection
The alleles most frequently found among the participants with lung affection were HLA-DRB1 * 0901 (50%), HLA-DRB4 (25%), HLA-DRB1 * 1201 (20%) and HLA-DRB3 (9%). No statistically significant association was found between any HLA-DR subtype and lung affection at alpha = 5% (chi-square and Fisher's exact tests) nor by bivariate analysis (Table 5) .
HLA-DRB1
* 0901 was the allele most frequently found among the participants with lung affection, identified in 50% of them.
Discussion
The clinical progression of RA is variable, including mild, moderate or destructive alterations, significant joint deformities, functional disability and extra-articular manifestations. The possibility of predicting the occurrence of extra-articular manifestations at the onset of disease might allow the establishment of more aggressive treatment at the early stages of affection [24] . HLA genotyping might contribute to defining the prognosis, especially when it is performed at an early stage of the disease, i.e., before the establishment of irreversible joint damage and appearance of extra-articular manifestations [25] . As ethnic differences in gene determinants might influence the expression of the disease [9] , we investigated the HLA system in individuals with RA and compared the results for individuals with and without lung affection.
The results of this study show that most participants (54.6%) exhibited some modality of lung affection. This high prevalence agrees with reports by previous authors, such as Skare et al. [26] , who found lung alteration in 55% of 71 individuals; Zrour et al. [27] , who found lung alteration in 49.3% of 75 individuals in Tunisia; and Bilgici et al. [28] , who found lung alteration in 67.3% of 52 individuals in Turkey. In addition, Teraski et al. [29] assessed a sample of individuals with RA and respiratory symptoms and found CT changes in 90% of them.
In our sample, HLA-DRB4 * 0101 was found in 51 participants (52.6%) and HLA-DRB1 That allele combination has also been associated with susceptibility to early manifestation of the disease [3] . The data on Latin America are heterogeneous. In Brazil, Bertolo et al. [9] found that the alleles HLA-DRB1 * 0101 and * 0102 were associated with susceptibility to RA and the alleles HLA-DRB1 * 0401 and * 0404 with the aggressive form of the disease. In a study with 67 Puerto Rican descendants, Teller et al. [32] found that the DR frequency was higher among individuals with RA compared to controls; however, the subtypes corresponding to the shared epitope (SE) were infrequent, especially subtype * 0411. In Chileans with RA, Gonzalez et al. [33] did not find any difference in the DR4 or DR1 frequency between individuals with RA and the controls, possibly due to the high prevalence of subtype * 0403 in that population.
In the study conducted by Do Monte et al. [34] * 04 were the most frequent alleles in our sample. Perhaps those alleles were the most frequently found because they are the most common in the overall population of Piaui.
HLA-DRB1
* 0901 was the allele most frequently found among the participants with lung affection, at a rate of 50%.
Although no statistically significant association was found between any HLA-DR subtype and lung affection through bivariate analysis, the pattern exhibited by HLA-DRB1 * 0301 and DRB1 * 0701 was different from the remainder of the subtypes, as the p-value was remarkably higher (p > 10%). Therefore, one might infer that those HLA subtypes may be associated with a lower risk of lung affection. As a function of the high variability in the distribution of the variables among the population, the sample size of this study yields insufficient statistical power to test such a possible protective effect (type II error -failure to find an actually existing association). The elucidation of that issue will require further studies with larger samples, although it is worth noting that the number of participants in this study was considerable compared to other studies [9, 32, 33] .
Conclusion
In this study, HLA-DRB1 * 0901 was the allele most frequently found among the participants with lung affection, identified in 50% of them. 
